CHIMENTO, Adele
 Distribuzione geografica
Continente #
NA - Nord America 7.094
AS - Asia 4.631
EU - Europa 3.341
SA - Sud America 1.290
AF - Africa 301
Continente sconosciuto - Info sul continente non disponibili 225
OC - Oceania 14
AN - Antartide 1
Totale 16.897
Nazione #
US - Stati Uniti d'America 6.741
SG - Singapore 1.867
BR - Brasile 939
CN - Cina 852
UA - Ucraina 796
IT - Italia 771
VN - Vietnam 768
DE - Germania 568
AT - Austria 285
BD - Bangladesh 240
FR - Francia 234
SE - Svezia 217
IN - India 178
CA - Canada 176
FI - Finlandia 135
TR - Turchia 123
AR - Argentina 120
SN - Senegal 111
HK - Hong Kong 93
KR - Corea 93
GB - Regno Unito 83
IQ - Iraq 70
ZA - Sudafrica 68
MX - Messico 65
ID - Indonesia 58
RU - Federazione Russa 57
PK - Pakistan 53
CO - Colombia 50
EC - Ecuador 48
CL - Cile 41
MA - Marocco 38
NL - Olanda 38
BE - Belgio 33
VE - Venezuela 32
UZ - Uzbekistan 25
PY - Paraguay 21
JP - Giappone 20
AE - Emirati Arabi Uniti 19
MY - Malesia 19
ES - Italia 18
PH - Filippine 18
SA - Arabia Saudita 18
GT - Guatemala 17
LT - Lituania 17
PL - Polonia 17
TN - Tunisia 17
CR - Costa Rica 16
AU - Australia 14
UY - Uruguay 14
DZ - Algeria 13
JM - Giamaica 13
PE - Perù 13
EG - Egitto 12
EU - Europa 12
JO - Giordania 12
KE - Kenya 12
NP - Nepal 12
HN - Honduras 11
BO - Bolivia 10
OM - Oman 10
BH - Bahrain 9
IL - Israele 9
NI - Nicaragua 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
ET - Etiopia 8
IE - Irlanda 8
PS - Palestinian Territory 8
AL - Albania 7
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
RO - Romania 7
SV - El Salvador 7
CW - ???statistics.table.value.countryCode.CW??? 6
GE - Georgia 6
KZ - Kazakistan 6
LB - Libano 6
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
BB - Barbados 5
EE - Estonia 5
GP - Guadalupe 5
KG - Kirghizistan 5
CH - Svizzera 4
MD - Moldavia 4
NG - Nigeria 4
PR - Porto Rico 4
RS - Serbia 4
SY - Repubblica araba siriana 4
BG - Bulgaria 3
BY - Bielorussia 3
CG - Congo 3
CY - Cipro 3
GA - Gabon 3
HU - Ungheria 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
Totale 16.656
Città #
Ashburn 861
Singapore 723
Chandler 722
San Jose 502
Council Bluffs 469
Jacksonville 444
Dallas 413
San Mateo 314
Boardman 285
Ho Chi Minh City 254
Beijing 235
New York 228
Dearborn 204
Rende 197
Vienna 191
Hanoi 160
Lawrence 116
Roxbury 114
São Paulo 113
Dakar 111
Lauterbourg 110
Milan 110
Shanghai 102
Helsinki 95
Seoul 93
Hong Kong 85
Izmir 81
Munich 76
Ottawa 75
Des Moines 72
Santa Clara 63
Brooklyn 57
Cambridge 57
Hefei 56
Los Angeles 56
Rome 49
Chicago 48
Turku 40
Da Nang 37
Toronto 37
Bremen 35
Frankfurt am Main 35
Grafing 35
Haiphong 33
Orem 33
Wilmington 33
Brussels 32
Inglewood 32
Phoenix 32
Ogden 31
Rio de Janeiro 28
Miano 26
Baghdad 25
Columbus 25
Guangzhou 25
Johannesburg 25
London 24
Seattle 24
Tashkent 24
Ann Arbor 22
Pune 22
Dhaka 21
Hanover 21
San Francisco 21
Biên Hòa 20
The Dalles 20
Hải Dương 19
Cosenza 18
Guayaquil 18
Mexico City 18
Montreal 18
Quito 18
Redwood City 18
Amsterdam 17
Florence 17
Jakarta 17
Kansas City 17
Santiago 17
Tokyo 17
Belo Horizonte 16
Guarulhos 16
Tianjin 16
Brasília 15
Chennai 15
Lahore 15
Mumbai 15
Naples 14
Omaha 14
Casablanca 13
Catanzaro 13
Charlotte 13
Fremont 13
Montevideo 13
Princeton 13
Falkenstein 12
Guatemala City 12
Medellín 12
Palermo 12
Salvador 12
San José 12
Totale 9.274
Nome #
6,6A-DIHYDRO FURO[3,2-B]FURAN-2-(5H)ONE DERIVATIVES, THEIR PREPARATION AND USE FOR TREATING TUMORS 275
17 β-estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocytes-derived cell line. 253
6-substituted carbazoles: synthesis and biological evaluation 241
A resveratrol derivative induces authophagic cell death in human breast cancer MCF-7 cell line. 237
27-hydroxycholesterol promotes adrenocortical cancer progression. 235
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment 234
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 211
Estrogen related receptor a (ERRa) a promising target for the therapy of adrenocortical carcinoma (ACC) 209
DAX-1, as an androgen-target gene, inhibits aromatase expression: A novel mechanism blocking estrogendependent breast cancer cell proliferation 207
Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines 205
A phenylacetamide resveratrol derivative exerts inhibitory effects on breast cancer cell growth 204
Activation of G-Protein-Coupled Estrogen Receptor (GPER) inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new target for ACC treatment. 200
Adrenocortical Carcinoma (ACC) Cells Rewire Their Metabolism to Overcome Curcumin Antitumoral Effects Opening a Window of Opportunity to Improve Treatment 197
A novel interplay between AR and DAX-1 controls aromatase expression in estrogen-dependent cancers 196
Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: Part i 196
Activation of GPER induces apoptosis in adrenocortical cancer (ACC) cells and controls tumor growth in vivo 194
Cholesterol as an endogenous ERRα agonist: A new perspective to cancer treatment 193
Cyclooxygenase (Cox)-2 regulating transcriptional and post-transcriptional activation of aromatase is involved in Leydig cell tumor proliferation 187
Cholesterol as new target for ACC therapy. 185
17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line 185
A Resveratrol Phenylacetamide Derivative Perturbs the Cytoskeleton Dynamics Interfering with the Migration Potential in Breast Cancer 182
17β-Estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ERα 181
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 180
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 180
Antitumoral activities of curcumin and recent advances to improve its oral bioavailability 179
Inhibition of cholesterol synthesis by simvastatin reduces ACC growth interfering with the regulation of mitochondrial respiratory chain mediated by estrogens/estrogen receptor alpha. 174
Defining the pathway responsible for Leydig cell tumors: the role of IGF-I and estrogens. 171
Cross talk of estrogen (E2) and IGF-II signalling in adrenocortical tumor cell proliferation. 168
The biochemical properties of the mitochondrial thiamine pyrophosphate carrier from Drosophila melanogaster 162
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 161
ERRα/PGC1-α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical cancer (ACC) 161
Cyclooxygenase-2 (COX-2) inhibitors down-regulate aromatase expression and inhibit proliferation of tumor Leydig cells 159
Catalytic Double Cyclization Process for Antitumor Agents against Breast Cancer Cell Lines 159
Antiproliferative effects of new N-alkylamino carbazole derivatives on breast cancer cell lines. 157
Statins reduce intratumor cholesterol affecting adrenocortical cancer growth 154
Antiproliferative effects of new carbazole derivative on breast cancer cell lines. 153
Central role of estrogen receptor α in adrenocortical tumor cell proliferation. 151
Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment 149
Retinoylation reaction of proteins in Leydig (TM-3) cells 148
SIRT1 is involved in adrenocortical cancer growth and motility 148
Role of GPER-Mediated Signaling in Testicular Functions and Tumorigenesis 147
Synthesis of a new bis(indolyl)methane that inhibits growth and induces apoptosis in human prostate cancer cells 146
XCT790 an inverse agonist of estrogen related receptor alpha (ERRalpha) inhibits cellular metabolism, motility and invasion of adrenocortical cancer cell line H295R. 146
Nandrolone and Stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation 145
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new therapy for ACC 143
Cross-talk between estrogen and IGF-II signalling in adrenocortical tumor cell proliferation. 143
Inhibition of human topoisomerase I and II and anti-proliferative effects on MCF-7 cells by new titanocene complexes 141
Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer 141
Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells 140
Estrogen Related Receptor α (ERRα) A Promising Target for the Therapy of Adrenocortical Carcinoma (ACC). 140
Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers 140
Ruolo dei recettori nucleari orfani SF-1, LRH-1, SHP e DAX-1 nella regolazione dell’espressione dell'aromatasi in cellule testicolari 139
Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined Treatment 138
Potential of Olive oil Phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies 137
The metabolic regulator estrogen-related receptor alpha as a therapeutic target in Adrenocortical Carcinoma (ACC). 136
Effects of Atrazine on Estrogen Receptor α- and G Protein-Coupled Receptor 30-Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts 135
GPER Signaling in Spermatogenesis and Testicular Tumors 133
DAX-1 at the Crossroads Between Androgens and Aromatase: A Novel Mechanism in the Inhibition of Estrogen-Dependent Cancer Cell Proliferation 132
G protein-coupled estrogen receptor-1 (GPER1)- and estrogen receptor α (ESR1)- dependent pathways regulate spermatocytes apoptosis. 132
Characterization of olive flower phenolic extract (OFE) and its anti-proliferative activity on MCF-7 Human Breast Cancer Cells. 132
Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol 132
Estrogen Related Receptor α (ERRα) As Potential Target for a New Adrenocortical Carcinoma (ACC) Therapy 131
GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway 131
“Involment of orphan nuclear receptors SF-1, LRH-1, DAX-1 and SHP in regulation of aromatase expression in Leydig cells”. 131
Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system 130
Oleuropeina ed idrossitirisolo attivano pathways GPER-dipendenti inducendo apoptosi in cellule tumorali mammarie SKBR3 negative per i recettori estrogenici α e β. 130
The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17β-estradiol on mouse spermatogonial GC-1 cell line 129
Resveratrol, Epigallocatechin Gallate and Curcumin for Cancer Therapy: Challenges from Their Pro-Apoptotic Properties 128
Cross-talk between GPER and growth factor signaling 127
Gper and ESRs are expressed in rat round spermatids and mediate oestrogen-dependent rapid pathways modulating expression of cyclin B1 and Bax 127
Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression 125
Involvment of Cyclooxygenase-2 (COX-2) in regulating estrogen-dependent Leydig cell tumor proliferation 124
Derivati 6,6A-Diidrofuro[3,2-b]furan-2-(5H)onici, loro preparazione e uso nel trattamento dei tumori 123
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to fight adrenocortical carcinoma (ACC) progression and as useful tool to determine ACC stem cell-like proprieties. 120
Mitotane activates GPER-dependent pathways leading to apoptosis of human adrenocortical carcinoma H295R cell line. 120
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to inhibit growth and invasion of adrenocortical carcinoma (ACC) Università della Calabria 119
L’attivazione selettiva di GPER inibisce la proliferazione e attiva l’apoptosi in cellule di Leydig tumorali. 118
Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells 118
Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: Potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment 117
Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor leydig cell proliferation 115
Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expression 115
Design, synthesis and biological evaluation of new 4-thiazolidinone derivatives in breast cancer cells. 114
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation 113
Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance 110
Rapid estrogen signaling in spermatogenesis 109
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 109
C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines 109
Steroid Receptor Signaling as Targets for Resveratrol Actions in Breast and Prostate Cancer 109
The Involvement of Natural Polyphenols in Molecular Mechanisms Inducing Apoptosis in Tumor Cells: A Promising Adjuvant in Cancer Therapy 107
Triiodothyronine decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse sertoli cell line, TM4 107
The novel estrogen receptor GRP30 mediates the proliferatiive effects induced by 17beta-estradiol onGC-1 mouse spermatogonial cell line 107
Olea europaea L. Flowers as a new promising anticancer natural product: phenolic composition, antiproliferative activity and apoptosis induction 106
GPR30 mediates estradiol-proliferative effects on GC-1 mouse spermatogonial cell line through ERK/Fos activation 104
Targeting estrogen receptor alpha reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMS) for ACC treatment. 104
Oleuropein and hydroxytyrosol activates GPER-dependent pathways inducing apoptosis in ER-negative breast cancer cells SKBR3. 103
The Estrogen Related Receptor α (ERRα) inverse agonist XCT-790 reduces adrenocortical cancer (ACC) H295R cells growth in vitro and in vivo. 102
Role of scaffold protein Proline-, Glutamic acid-, and Leucine-Rich protein 1 (PELP1) in the modulation of adrenocortical cancer cell growth 102
Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells 102
Triiodothyronine (T3) decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse Sertoli cell line TM4 101
Role of IGF-I and estrogens in Leydig cell tumorogenesis. 101
Totale 14.936
Categoria #
all - tutte 89.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.051


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.247 0 0 0 82 193 40 10 340 15 14 171 382
2022/20231.722 210 234 119 199 221 144 7 185 210 54 73 66
2023/20241.066 117 46 67 60 65 286 41 40 70 49 38 187
2024/20252.165 150 280 63 123 167 105 72 125 388 184 215 293
2025/20266.630 749 240 710 531 1.199 452 716 354 518 498 311 352
2026/20271.678 315 118 307 938 0 0 0 0 0 0 0 0
Totale 16.897